TITLE

Invasive strategy within 24 hours of thrombolysis reduced death, nonfatal reinfarction, and ischemia-induced revascularization in STEMI

PUB. DATE
March 2005
SOURCE
ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article cites a study, which focuses on the effectiveness of routine invasive strategy (IS) within 24 hours of thrombolysis (TL) than an ischemia-guided conservative strategy (CS) for reducing clinical outcomes in patients with thrombolized ST-segment elevated myocardial infarction (STEMI). In patients with thrombolized ST-segment elevated myocardial infarction, a routine invasive strategy within 24 hours of thrombolysis was better than an ischemia-guided conservative strategy for reducing death, nonfatal reinfarction, and ischemia-induced revascularization. The study was published in the 2004 issue of the journal "Lancet."
ACCESSION #
16486577

 

Related Articles

  • Review: Rescue percutaneous coronary intervention but not repeated fibrinolysis is effective for failed fibrinolysis in STEMI: COMMENTARY. Berger, Peter; Skelding, Kimberly // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p11 

    The authors reflect on a study, conducted by H.C. Wijeysundera and colleagues, which focuses on the benefits and risks of rescue percutaneous coronary intervention (PCI) or repeated fibrinolytic therapy compared with conservative management in patients with ST-segment elevation myocardial...

  • Invasive strategy underused in ACS.  // Heart;Jun2008, Vol. 94 Issue 6, p818 

    The article presents a study on the application of invasive strategy in the treament of patients with acute coronary syndromes (ACS). The study investigated the selection of patients for cardiac catheterisation and used the Thrombolysis in Myocardial Infarction (TIMI) risk score. Results showed...

  • Effects of spironolactone on cardiac sympathetic nerve activity and left ventricular remodelling after reperfusion therapy in patients with first ST-segment elevation myocardial INFARCTION. Kasama, Shu; Toyama, Takuji; Sumino, Hiroyuki; Kumakura, Hisao; Takayama, Yoshiaki; Minami, Kazutomo; Ichikawa, Shuichi; Matsumoto, Naoya; Sato, Yuichi; Kurabayashi, Masahiko // Heart;May2011, Vol. 97 Issue 10, p8 

    The article discusses a study to evaluate the hypothesis that spironolactone improves the cardiac sympathetic nerve activity (CSNA) in patients with a first ST-segment elevation myocardian infarction (STEMI) undergoing primary coronary angioplasty. Patients admitted to the coronary care unit...

  • Is the National Service Framework standard for thrombolytic therapy achievable in a rural area? A-M. Harney; R. McClean; J. Rawles; D. Stewart // Journal of Public Health Medicine;Mar2003, Vol. 25 Issue 1, p19 

    The National Service Framework (NSF) for coronary heart disease requires that patients with acute myocardial infarction should start thrombolytic therapy within 60 min of the patient making contact with the National Health Service. In an audit of 700 patients with suspected acute myocardial...

  • Prasugrel: A Review of its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Duggan, Sean T.; Keating, Gillian M. // Drugs;Aug2009, Vol. 69 Issue 12, p1707 

    Summary: Prasugrel (Efient®) is a potent, selective and irreversible inhibitor of adenosine diphosphate (ADP)-mediated platelet aggregation that is indicated for the prevention of atherothrombotic events in patients with acute coronary syndromes (ACS) [comprising unstable angina...

  • COMMENTARY: Invasive strategy within 24 hours of thrombolysis reduced death, nonfatal reinfarction, and ischemia-induced revascularization in STEMI. Hillegass, William B.; Brott, Brigitta C. // ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p38 

    The article reports that invasive strategy within 24 hours of thrombolysis reduced death, nonfatal reinfarction, and ischemia-induced revascularization in ST-segment elevated myocardial infarction (STEMI). In STEMI, randomized trials that compare an interventional strategy with TL have shown 30...

  • JournalScan. Malik, Iqbal // Heart;Jun2002, Vol. 87 Issue 6, p590 

    This article presents research results related to heart disease. In a cohort of over 2000 patients, more than 75 years old who had a myocardial infarction, only 63% of eligible patients got thrombolysis while 27% of thrombolysis recipients had what are regarded as absolute contraindications to...

  • Patency and Reinfarction in Late-Entry Myocardial Infarct Patients Treated with Reperfusion Therapy. van't Hof, Arnoud W.; Zijlstra, Felix; de Boer, Menko-Jan; Liem, Ay Lee; Hoorntje, Jan C.; Suryapranata, Harry // Angiology;Mar1997, Vol. 48 Issue 3, p215 

    Patency of the infarct-related vessel is associated with a more favorable long-term prognosis after acute myocardial infarction (AMI). High infarct vessel patency is reported for early reperfusion therapy, hut data on patency and its possible effect on clinical outcome are less abundant for...

  • The Efficacy Of Thrombolytic Treatment On Patients Who Are Above 75 Years Of Age. Keles, Telat; Akar, Nihal; Gürsel, Koray; Canbay, Alper; Şahin, Deniz; Durmaz, Tahir; Diker, Erdem; Aydogdu, Sinan // Internet Journal of Cardiology;2006, Vol. 3 Issue 1, p2 

    Background: For acute myocardial infarction (AMI) patients above the age of 75, the efficacy of thrombolytic treatment could not be demonstrated clearly. Recently, depending on the data obtained from observational studies, it has been advocated that thrombolytic treatment might not be showing...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics